AXT, Inc. (NASDAQ: AXTI) – Q1 2026 Earnings
AXT, Inc. (NASDAQ: AXTI) – Q1 2026 Earnings
Press release and earnings call link
Section 1: Short Tear Sheeet
AXT, Inc. is a compound semiconductor substrate manufacturer. In plain English, it makes specialized wafer materials used in optical communications, data centers, 5G infrastructure, sensors, lasers, wireless devices, and other electronics where standard silicon wafers are not enough. Its most important near-term growth driver is indium phosphide (InP), a substrate used in high-speed optical transmission for artificial intelligence (AI) data centers and next-generation optical networking. The company is transitioning from a cyclical, loss-making substrate supplier into a potential AI infrastructure supply-chain beneficiary. Q1 2026 showed a sharp turnaround: revenue grew to $26.9 million from $19.4 million year over year, gross margin improved to 29.6% GAAP from negative 6.4%, and the company nearly reached non-GAAP breakeven. The press release framed the story around a $632.5 million capital raise and capacity expansion, while the call added far more detail on backlog, pricing, customer demand, export permits, long-term supply agreements, and a path to profitability.
Quarterly Results
Earnings Release Date: Apr. 30, 2026
Stock Price: $60.63
Market Cap: $2711.3 million
Q1 2026 sales of $26.9 million vs $19.4 million in the prior year
Q1 2026 Non-GAAP Adjusted EPS of $(0.01) vs $(0.19) in the prior year
Q1 2026 GAAP Diluted EPS of $(0.03) vs $(0.20) in the prior year
Quick Takeaway
AXT is in a growth inflection phase, focusing on indium phosphide capacity expansion for AI data centers, optical transceivers, and China’s semiconductor supply-chain buildout. While record backlog, Q2 profitability guidance, pricing power, and long-term supply agreement discussions create a credible bullish setup, there are concerns about export permits, dilution, capex intensity, and execution risk in scaling qualified capacity. Execution on permit approvals, capacity ramp, margin expansion, and customer agreements will be critical for future performance.
Press Release vs Call Transcript Comparison
AXT’s Q1 was not just a better quarter; it was a potential business-model transition quarter. Revenue grew 39% year over year, which is strong for a semiconductor materials company coming out of a weak demand period. More important, gross margin swung from negative territory to nearly 30%, which suggests volume, mix, and manufacturing absorption are improving together. The call made clear that indium phosphide is becoming the center of gravity for the company, while gallium arsenide and raw materials remain supporting businesses.
The biggest investment debate is whether AXT is becoming a scarce supplier in a supply-constrained AI optical components market, or whether current demand will remain too dependent on export permits, China policy, and capacity execution. The call supports the bullish case more strongly than the press release because it includes backlog, long-term agreement discussions, hyperscaler involvement, pricing actions, China demand acceleration, and Q2 profitability guidance. However, the same call also highlights risks the press release does not fully unpack: heavy capex, dilution, permit timing, and the challenge of scaling production without yield or quality issues.
Investor Underappreciation Signals
✅Indium phosphide backlog inflection — AXT disclosed more than $100 million of indium phosphide backlog, a large figure relative to Q1 total revenue of $26.9 million, and investors may be underestimating how quickly this backlog could change the company’s revenue base if permits and capacity line up.
✅Q2 profitability setup — The press release shows a near-breakeven Q1, but the call adds guidance for GAAP and non-GAAP profitability in Q2, which could shift investor perception from “turnaround story” to “earnings inflection story.”
✅Hyperscaler pull-through — The call indicates that hyperscalers and hardware companies are encouraging suppliers to enter long-term agreements with AXT, which could be overlooked because AXT does not directly sell to all end customers but may still benefit from their supply-chain planning.
✅Pricing power emerging — Management said it is raising some indium phosphide prices and globalizing pricing across regions, which investors may miss if they only focus on volume growth rather than the potential for margin expansion.
✅China demand without export-permit friction — China demand more than doubled in Q1 and is expected to double again in Q2, and investors may underappreciate that shipments within China do not require the export permits that create uncertainty for U.S.-bound revenue.
✅Capacity roadmap is bigger than the press release suggests — The press release mentions capacity expansion, but the call lays out a path from roughly $35 million per quarter of indium phosphide capacity by end-2026 to $65 million to $70 million by late 2027 or early 2028, which could reset the market’s view of AXT’s revenue potential.
✅Supply-chain integration advantage — Management emphasized AXT’s own furnaces, raw-material supply, and manufacturing space, which may be underappreciated because investors often focus on demand while missing the execution advantage in scaling scarce substrate capacity.
Section 2: Supplementary Information
Positive Insights
Negative Insights
Tariff Risk
Tariffs were mentioned only in the forward-looking disclaimer, where AXT referenced global economic and political conditions, including trade tariffs and import/export restrictions. The substantive discussion focused more on export permits than tariffs. Management did not quantify tariff exposure, did not provide a tariff-related revenue or margin impact, and did not describe specific tariff mitigation actions such as shifting production, renegotiating contracts, or restructuring the supply chain.
The more immediate trade-policy risk is export permitting from China, especially for U.S.-based customers. Management said Q2 and future growth depend heavily on permit timing, and U.S. permits remain pending. From an investor standpoint, tariff risk is less developed in the call, but trade-policy risk broadly remains central to the thesis because it can determine when backlog converts to revenue.
Hot Stock Trends Analysis
Previous Earnings Call
Quarter-over-quarter comparison
In Q4 2025, AXT sounded like a company with a major AI-driven demand opportunity but still constrained by export permits and timing uncertainty. Management had growing backlog, expanding customer interest, and a plan to double capacity, but the quarter was still defined by sequential revenue decline, missed permit timing, and a guided loss.In Q1 2026, the story moved from recovery to inflection. Revenue improved, margins expanded sharply, indium phosphide backlog grew from more than $60 million to more than $100 million, and management guided Q2 to profitability, shifting the investor debate from whether demand is real to whether AXT can execute on permits, capacity, pricing, and production.
Year-over-year comparison
In Q1 2025, AXT was trying to stabilize after a difficult quarter. The company had real AI/data center opportunities, but the narrative was dominated by export restrictions, delayed indium phosphide shipments, negative gross margin, and gallium arsenide yield issues. Management’s message was cautious: demand existed, but the company needed permits, yield recovery, better product mix, and margin repair.
By Q1 2026, AXT’s narrative had advanced from stabilization to growth inflection. The company was no longer mainly explaining what went wrong; it was laying out a much larger indium phosphide opportunity backed by $100 million-plus backlog, improving margins, Q2 profitability guidance, customer expansion, pricing power, and a funded capacity roadmap. The investor debate shifted from “can AXT recover?” to “how much of this AI optical demand can AXT convert into revenue and earnings?”